![]() Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 1: cognitive functioning. Whiteside D.M., Basso M.R., Naini S.M., Porter J., Holker E., Waldron E.J., et al. Neurocognitive profiles in patients with persisting cognitive symptoms associated with covid-19. Krishnan K., Miller A.K., Reiter K., Bonner-Jackson A. Cognitive impairment after covid-19-a review on objective test data. An Italian multicenter retrospective-prospective observational study on neurological manifestations of covid-19 (NEUROCOVID) Neurol Sci. To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often. įerrarese C., Silani V., Priori A., Galimberti S., Agostoni E., Monaco S., et al. Therefore, patients with persistent cognitive complaints in the setting of PASC who score in the normal range on the MoCA should be referred for formal NP assessment.ĬOVID-19 Cognitive deficits Montreal cognitive assessment Neuropsychological testing “Brain fog”.Ĭopyright © 2022 Elsevier Inc. The MoCA may not be accurate for detecting neither mild nor more severe degrees of diminished NP test performance in PASC. The MoCA had an accuracy of 63.3% at detecting any degree of diminished NP performance, and an accuracy of 73.3% at detecting extremely low NP performance. MoCA score was inversely correlated with fatigue and depression measures and ethnic minority participants scored on average lower, despite similar education and estimated premorbid function. ![]() The overall sample had a mean score of 26.1 on the MoCA, with approximately one third screening below the cutoff score of 26, similar to the rate of extremely low NP test performance. Sixty participants underwent neuropsychological, psychiatric, and medical assessments, as well as the Montreal Cognitive Assessment, 6-8 months after acute COVID-19 infection. To determine the utility of the MoCA to screen for cognitive impairment in PASC. ![]() The Montreal Cognitive Assessment (MoCA) has been used to estimate prevalence of cognitive impairment in many studies of PASC, and is commonly employed as a screening test in this population, however, its validity has not been established. J Int Neuropsychol Soc 2012 18:1031–1040.Cognitive complaints are one of the most frequent symptoms reported in post-acute sequelae of COVID-19 (PASC). Montreal Cognitive Assessment (MoCA): validation study for vascular dementia. J Neural Transm (Vienna) 2016 123:431–438.įreitas S, Simões MR, Alves L, Vicente M, Santana I. ![]() MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J Geriatr Psychiatry 2012 27:1189–1194.īiundo R, Weis L, Bostantjopoulou S, et al. Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment. Neuroimaging signatures and cognitive correlates of the Montreal cognitive assessment screen in a nonclinical elderly sample. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Nasreddine ZS, Phillips NA, Bédirian V, et al. Neuropsychologists are well versed in the assessment of performance and symptom validity and thus may be well suited to explore the influences of abnormal performances on cognitive screening. Causal inferences about neurologic and neurocognitive impairment, particularly in the context of mild TBI, wherein the natural course of recovery is well known, should therefore be made cautiously when such inferences are based heavily on MoCA scores. Performance on the MoCA is influenced by task engagement and symptom validity. Self-reported distress (both posttraumatic stress disorder symptoms and neurobehavioral cognitive symptoms) was also related to MoCA performance. Failure of both the SVT and at least 1 PVT yielded the lowest MoCA scores. Background: The Montreal Cognitive Assessment (MoCA) is a popular cognitive screening tool used in stroke, but lacks sensitivity for detecting impairment in stroke-relevant domains of processing speed, non-verbal memory and executive functions. Successively worse MoCA performances were associated with a greater number of PVT failures ( ps < 0.05). Commonly used measures of neuropsychological functioning and performance and symptom validity were also administered to aid in diagnosis. The MoCA was administered as part of the evaluation. Of 198 consecutively referred veterans to a Veterans Administration TBI/Polytrauma Clinic, 117 were included in the final sample. We evaluated Montreal Cognitive Assessment (MoCA) performance in a veteran traumatic brain injury (TBI) population, considering performance validity test (PVT) and symptom validity test (SVT) data, and explored associations of MoCA performance with neuropsychological test performance and self-reported distress.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |